Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 71

1.

Chemotherapy and tumor immunity: an unexpected collaboration.

Emens LA.

Front Biosci. 2008 Jan 1;13:249-57. Review.

2.

Leveraging the activity of tumor vaccines with cytotoxic chemotherapy.

Emens LA, Jaffee EM.

Cancer Res. 2005 Sep 15;65(18):8059-64. Review.

3.

Combinatorial treatments including vaccines, chemotherapy and monoclonal antibodies for cancer therapy.

Baxevanis CN, Perez SA, Papamichail M.

Cancer Immunol Immunother. 2009 Mar;58(3):317-24. doi: 10.1007/s00262-008-0576-4. Epub 2008 Aug 15. Review.

PMID:
18704409
4.

Chemoimmunotherapy.

Emens LA.

Cancer J. 2010 Jul-Aug;16(4):295-303. doi: 10.1097/PPO.0b013e3181eb5066. Review.

5.

Marrying immunotherapy with chemotherapy: why say IDO?

Muller AJ, Prendergast GC.

Cancer Res. 2005 Sep 15;65(18):8065-8. Review.

6.

Role of Local Radiation Therapy in Cancer Immunotherapy.

Demaria S, Golden EB, Formenti SC.

JAMA Oncol. 2015 Dec;1(9):1325-32. doi: 10.1001/jamaoncol.2015.2756. Review.

PMID:
26270858
7.

Roadmap to a better therapeutic tumor vaccine.

Emens LA.

Int Rev Immunol. 2006 Sep-Dec;25(5-6):415-43. Review.

PMID:
17169782
8.

Targeting the immune system in cancer.

Chaudhuri D, Suriano R, Mittelman A, Tiwari RK.

Curr Pharm Biotechnol. 2009 Feb;10(2):166-84. Review.

PMID:
19199949
9.

The anticancer immune response: indispensable for therapeutic success?

Zitvogel L, Apetoh L, Ghiringhelli F, André F, Tesniere A, Kroemer G.

J Clin Invest. 2008 Jun;118(6):1991-2001. doi: 10.1172/JCI35180. Review.

10.

Cytokine, chemokine, and co-stimulatory fusion proteins for the immunotherapy of solid tumors.

Khawli LA, Hu P, Epstein AL.

Handb Exp Pharmacol. 2008;(181):291-328. Review.

PMID:
18071951
11.

Twelve immunotherapy drugs that could cure cancers.

Cheever MA.

Immunol Rev. 2008 Apr;222:357-68. doi: 10.1111/j.1600-065X.2008.00604.x. Review.

PMID:
18364014
12.

The interplay of immunotherapy and chemotherapy: harnessing potential synergies.

Emens LA, Middleton G.

Cancer Immunol Res. 2015 May;3(5):436-43. doi: 10.1158/2326-6066.CIR-15-0064. Review.

13.

Combining immunotherapy and anticancer agents: the right path to achieve cancer cure?

Apetoh L, Ladoire S, Coukos G, Ghiringhelli F.

Ann Oncol. 2015 Sep;26(9):1813-23. doi: 10.1093/annonc/mdv209. Epub 2015 Apr 28. Review.

PMID:
25922066
14.

How to improve the immunogenicity of chemotherapy and radiotherapy.

Ma Y, Conforti R, Aymeric L, Locher C, Kepp O, Kroemer G, Zitvogel L.

Cancer Metastasis Rev. 2011 Mar;30(1):71-82. doi: 10.1007/s10555-011-9283-2. Review.

PMID:
21298323
15.

[The interplay of immunotherapy and chemotherapy, a novel approach].

Hanoteau A, Henin C, Moser M.

Med Sci (Paris). 2016 Apr;32(4):353-61. doi: 10.1051/medsci/20163204013. Epub 2016 May 2. Review. French.

16.

Cancer chemotherapy: not only a direct cytotoxic effect, but also an adjuvant for antitumor immunity.

Ménard C, Martin F, Apetoh L, Bouyer F, Ghiringhelli F.

Cancer Immunol Immunother. 2008 Nov;57(11):1579-87. doi: 10.1007/s00262-008-0505-6. Epub 2008 Mar 28. Review.

PMID:
18369619
17.

Targeting myeloid cells using nanoparticles to improve cancer immunotherapy.

Amoozgar Z, Goldberg MS.

Adv Drug Deliv Rev. 2015 Aug 30;91:38-51. doi: 10.1016/j.addr.2014.09.007. Epub 2014 Oct 2. Review.

PMID:
25280471
18.

Therapeutic cancer vaccines: the latest advancement in targeted therapy.

Bilusic M, Madan RA.

Am J Ther. 2012 Nov;19(6):e172-81. doi: 10.1097/MJT.0b013e3182068cdb. Review.

19.

Overview of resistance to systemic therapy in patients with breast cancer.

Gonzalez-Angulo AM, Morales-Vasquez F, Hortobagyi GN.

Adv Exp Med Biol. 2007;608:1-22. Review.

PMID:
17993229
20.

Therapeutic Cancer Vaccines.

Ye Z, Li Z, Jin H, Qian Q.

Adv Exp Med Biol. 2016;909:139-67. doi: 10.1007/978-94-017-7555-7_3. Review.

PMID:
27240458

Supplemental Content

Support Center